Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
02/12/2014 | EP2694113A2 Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics |
02/12/2014 | EP2694112A2 Anti-tumor antibody-tumor suppressor fusion protein compositions and methods of use for the treatment of cancer |
02/12/2014 | EP2694111A1 Antibody-drug conjugates |
02/12/2014 | EP2694110A1 Novel polysaccharide derivatives and dosage forms |
02/12/2014 | EP2694096A1 Melanocyte-stimulation hormone for suppressing inflammation reactions in hemodialysis |
02/12/2014 | EP2694076A1 Nasal formulations of benzodiazepine |
02/12/2014 | EP2694040A2 Osmotic mediated release synthetic nanocarriers |
02/12/2014 | EP2694038A2 Pharmaceutical composition |
02/12/2014 | EP2694034A1 Ophthalmic preparations based on pacap (pituitary adenylate cyclase activating polypeptide) which restore the normal visual function in early glaucoma |
02/12/2014 | EP2693883A1 Silyl monomers capable of multimerizing in an aqueous solution, and methods of using same |
02/12/2014 | CN103582496A Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom |
02/12/2014 | CN103582484A Pulmonary delivery of 17-hydroxyprogesterone caproate (17-HPC) |
02/12/2014 | CN103571843A Nano-particle wrapped with small RNA (Ribose Nucleic Acid) for inhibiting embryo implantation |
02/12/2014 | CN103571814A Sulfhydryl modified recombinant human arginase I, as well as preparation method and application thereof |
02/12/2014 | CN103570942A Polyethyleneimine function cation polymer derived from natural cholesterol, synthesis method and uses thereof |
02/12/2014 | CN103570834A Methoxy polyethylene glycol-modified erythropoietin mimic peptide derivative |
02/12/2014 | CN103566417A Paste-like bone cement |
02/12/2014 | CN103566416A Bone cement in paste form |
02/12/2014 | CN103566381A Multifunctional magnetic nano particle and preparation method thereof |
02/12/2014 | CN103566379A Preparation and application of intracellular triggering reduction sensitive drug linked gene targeted co-carrier |
02/12/2014 | CN103566377A Targeted immunotherapy for cancer |
02/12/2014 | CN103566376A Formula and preparation method of preparation delivered through mucous membrane |
02/12/2014 | CN103566375A Lansoprazole composition lyophilized powder injection |
02/12/2014 | CN103566374A Polyethyleneimine lipid composite nano-carrier and preparation method thereof, and polyethyleneimine lipid composite nanometer gene drug |
02/12/2014 | CN103566373A Drug composition containing cholesterol absorption inhibitor and HMG-CoA reductase inhibitor, preparation method and use thereof |
02/12/2014 | CN103566368A Sheet-like preparation containing allergen and manufacturing method thereof |
02/12/2014 | CN103566354A Pharmaceutical composition containing derivatives of GLP-1 analogue or medicinal salts thereof |
02/12/2014 | CN103566198A Application of gastrodia elata and gastrodin in preparation of product used for treating non-alcoholic fatty liver disease |
02/12/2014 | CN103566116A Preparation method of spray for stretching tendon and promoting blood circulation |
02/12/2014 | CN103565996A Pepper nano powder, pepper supported nano powder as well as preparation method and application thereof |
02/12/2014 | CN103565941A Rheum officinale anthraquinone oral colon targeted drug delivery composition and application thereof |
02/12/2014 | CN103565915A Folium isatidis and sophora flavescens external medicament, preparation and application thereof |
02/12/2014 | CN103565909A Liquorice particles and preparation method thereof |
02/12/2014 | CN103565902A Slow release agent as well as preparation method and application thereof |
02/12/2014 | CN103565828A Chlorine dioxide gel and manufacturing method thereof |
02/12/2014 | CN103565826A High-density compound calcium carbonate |
02/12/2014 | CN103565807A Olmesartan medoxomil/amlodipine pharmaceutical composition |
02/12/2014 | CN103565778A Lutein microcapsule and preparation method thereof |
02/12/2014 | CN103565777A Preparation method of sodium ferrous chlorophyll-ethyl cellulose microcapsule |
02/12/2014 | CN103565776A Stable lurasidone capsule pharmaceutical composition |
02/12/2014 | CN103565775A Extraction solution soft capsule and preparation method for same |
02/12/2014 | CN103565774A Glipizide controlled release composition as well as preparation method thereof |
02/12/2014 | CN103565773A Pharmaceutical composition of prasugrel hydrochloride |
02/12/2014 | CN103565772A Glipizide controlled release composition and preparation method thereof |
02/12/2014 | CN103565771A Oral solid preparation containing indissolvable drug minodronic acid |
02/12/2014 | CN103565766A Mesalazine enteric-coated sustained release tablet |
02/12/2014 | CN103565765A Preparation of ibuprofen orally-disintegrating pellet coated by compound essence powder and capable of hierarchically releasing drug |
02/12/2014 | CN103565764A Mitiglinide calcium composition tablets and preparation method thereof |
02/12/2014 | CN103565763A Dronedarone hydrochloride tablet and preparation method thereof |
02/12/2014 | CN103565762A Blonanserin pharmaceutical composition with improved oral absorptivity |
02/12/2014 | CN103565761A Galanthamine hydrobromide orally disintegrating tablet |
02/12/2014 | CN103565760A Fosaprepitant dimeglumine freeze-dried powder and preparation method thereof |
02/12/2014 | CN103565759A Ceftibuten composition freeze-dried powder for injection |
02/12/2014 | CN103565758A Bromhexine hydrochloride composition freeze-dried powder for injection |
02/12/2014 | CN103565753A Ambroxol hydrochloride grain and preparation method thereof |
02/12/2014 | CN103565750A Racecadotril particle as well as preparation method thereof |
02/12/2014 | CN103565749A Duloxetine hydrochloride enteric pellet and preparation method thereof |
02/12/2014 | CN103565748A Polyethylene glycol 4000 powder |
02/12/2014 | CN103565747A Esomeprazole composition and preparation method thereof |
02/12/2014 | CN103565746A Apramycin liposome and preparation method thereof |
02/12/2014 | CN103565744A Macromolecular phosphatidylglycerol nanoliposome, and preparation methods and applications thereof |
02/12/2014 | CN103565742A Fluorometholone eye drops |
02/12/2014 | CN103565736A Hydroxyethyl starch 130 sodium acetate Ringer injection and preparation method thereof |
02/12/2014 | CN103565735A Oral liquor containing dextromethorphan hydrobromide as well as preparation method thereof |
02/12/2014 | CN103565734A Bendazac lysine eye drops as well as preparation method thereof |
02/12/2014 | CN103565732A Veterinary florfenicol long-acting injection and preparation method thereof |
02/12/2014 | CN103565731A Thymopentin injection composition |
02/12/2014 | CN103564429A Novel soft capsule oily liquid accessory capable of improving sleep |
02/12/2014 | CN102743384B Sitafloxacin-containing pharmaceutical composition |
02/12/2014 | CN102698278B Pharmaceutical composition for external application and adhesive skin patch |
02/12/2014 | CN102697660B Method for eliminating static electricity in micro-pill room |
02/12/2014 | CN102657607B Tilmicosin stabilizing agent and preparation method thereof |
02/12/2014 | CN102643225B Ionic liquid, nano fluorescent ellipsoid and preparation method thereof |
02/12/2014 | CN102552383B Compound jellyfish antihypertensive dispersible tablet and preparation method thereof |
02/12/2014 | CN102548543B Slow-release cilostazol tablet having improved elution rate and minimal side effects |
02/12/2014 | CN102525985B Cefaclor sustained-release tablet and preparation method thereof |
02/12/2014 | CN102512367B Formula of novel docosahexaenoic acid (DHA) fat emulsion preparation and preparation method thereof |
02/12/2014 | CN102341125B Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcohol |
02/12/2014 | CN102186468B Urea-based film-forming solution for treating nail psoriasis |
02/12/2014 | CN101678119B Von willebrand factor- and factor VIII-polymer conjugates having releasable linkage |
02/12/2014 | CN101460150B Directly compressible composite for orally disintegrating tablets |
02/11/2014 | US8648185 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
02/11/2014 | US8648175 Stable pharmaceutical composition comprising erythropoietin |
02/11/2014 | US8648119 Controlled release immunomodulator compositions and methods for the treatment of otic disorders |
02/11/2014 | US8648108 Medical compositions for intravesical treatment of bladder cancer |
02/11/2014 | US8648082 Gum resin as a carrier for topical application of antimicrobial agents |
02/11/2014 | US8648056 Composition for local anesthesia |
02/11/2014 | US8648042 Pharmaceutical compositions |
02/11/2014 | US8648034 Method and applications of peptide-mediated mitochondrial delivery system |
02/11/2014 | US8647826 Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer |
02/11/2014 | US8647687 Isoamyl acetate for weight management |
02/11/2014 | US8647668 Tablet quickly disintegrating in oral cavity |
02/11/2014 | US8647645 Enhanced moisture barrier immediate release film coating systems and substrates coated therewith |
02/11/2014 | US8647643 Farnesoid-X-receptor antagonist as a vaccine adjuvant |
02/11/2014 | US8647603 Devices and methods for the treatment of cancer |
02/11/2014 | CA2756207C Compositions of estrogen-cyclodextrin complexes |
02/11/2014 | CA2717246C Use of quinoline and quinolizinone derivatives as chemotherapeutic agents |
02/11/2014 | CA2672021C Factor ix moiety-polymer conjugates having a releasable linkage |
02/11/2014 | CA2634131C Protein formulations with reduced viscosity and uses thereof |
02/11/2014 | CA2577702C New polymorphic form of inulin and uses thereof |